Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multi-disciplinary approach

Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multi-disciplinary approach

The Nephrotic Syndrome Study Network (NEPTUNE) is a North American multi-center collaborative consortium established to develop a translational research infrastructure for Nephrotic Syndrome. This includes a longitudinal observational cohort study, a pilot and ancillary studies program, a training p...

Full description

Saved in:
Bibliographic Details
Published in:Kidney international 2013-01, Vol.83 (4), p.749-756
Main Authors: Gadegbeku, Crystal A., Gipson, Debbie S., Holzman, Larry, Ojo, Akinlolu O., Song, Peter, Barisoni, Laura, Sampson, Matthew G., Kopp, Jeffrey, Lemley, Kevin V., Nelson, Peter, Lienczewski, Chrysta, Adler, Sharon, Appel, Gerald, Cattran, Daniel, Choi, Michael, Contreras, Gabriel, Dell, Katherine, Fervenza, Fernando C., Gibson, Keisha, Greenbaum, Larry A., Hernandez, Joel, Hewitt, Stephen, Hingorani, Sangeeta, Hladunewich, Michelle, Hogan, Marie, Hogan, Susan, Kaskel, Frederick, Lieske, John, Meyers, Kevin E.C., Nachman, Patrick, Nast, Cynthia, Neu, Alicia M., Reich, Heather, Sedor, John, Sethna, Christine, Trachtman, Howard, Tuttle, Katherine, Zhdanova, Olga, Zilleruelo, Gastòn E., Kretzler, Matthias
Format: Article
Language:eng
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Nephrotic Syndrome Study Network (NEPTUNE) is a North American multi-center collaborative consortium established to develop a translational research infrastructure for Nephrotic Syndrome. This includes a longitudinal observational cohort study, a pilot and ancillary studies program, a training program, and a patient contact registry. NEPTUNE will enroll 450 adults and children with minimal change disease, focal segmental glomerulosclerosis and membranous nephropathy for detailed clinical, histopathologic, and molecular phenotyping at the time of clinically-indicated renal biopsy. Initial visits will include an extensive clinical history, physical examination, collection of urine, blood and renal tissue samples, and assessments of quality of life and patient-reported outcomes. Follow-up history, physical measures, urine and blood samples, and questionnaires will be obtained every 4 months in the first year and bi-annually, thereafter. Molecular profiles and gene expression data will be linked to phenotypic, genetic, and digitalized histologic data for comprehensive analyses using systems biology approaches. Analytical strategies were designed to transform descriptive information to mechanistic disease classification for Nephrotic Syndrome and to identify clinical, histological, and genomic disease predictors. Thus, understanding the complexity of the disease pathogenesis will guide further investigation for targeted therapeutic strategies.
ISSN:0085-2538
1523-1755